Title : Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.

Pub. Date : 2013 Aug

PMID : 23969971






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Because oxaliplatin and nedaplatin are effective against cisplatin-resistant ovarian cancer in clinical trials and signal transducer and activator of transcription 3 (STAT3) is associated with cisplatin resistance, we investigated whether overcoming cisplatin resistance by oxaliplatin and nedaplatin was associated with the STAT3 pathway in ovarian cancer. nedaplatin signal transducer and activator of transcription 3 Homo sapiens